Prevalence of erectile dysfunction and its treatment in a Mexican population: distinguishing between erectile function change and dysfunction

Journal of Men's Health

Volumn 6, Issue 1, 2009, Pages 56-62

  Wentzell, Emily ^a   Salmerón, Jorge ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

Author keywords

Erectile dysfunction; Mexico; Treatment seeking

Indexed keywords

ADULT; ALTERNATIVE MEDICINE; ARTICLE; ERECTILE DYSFUNCTION; HELP SEEKING BEHAVIOR; HUMAN; MAJOR CLINICAL STUDY; MALE; MEXICO; PREVALENCE; PRIORITY JOURNAL; SELF REPORT; SEXUAL FUNCTION;

EID: 60749097674     PISSN: 18756867     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jomh.2008.09.009     Document Type: Article

References (19)

1. Potts A., Grace V., Gavey N., and Vares T. "Viagra stories:" challenging 'erectile dysfunction'. Soc Sci Med 59 (2004) 489-499
2. Tiefer L. In pursuit of the perfect penis: the medicalization of male sexuality. Sex is Not a Natural Act and Other Essays (1995), Westview Press, Boulder 141-156
3. Loe M. The Rise of Viagra: How the Little Blue Pill Changed Sex in America (2004), New York University Press, New York
4. Tiefer L. The medicalization of impotence: normalizing phallocentrism. Gend Soc 8 3 (1994) 363-377
5. Prentice A.M. The emerging epidemic of obesity in developing countries. Int J Epidemiol 35 1 (2005) 93-99
6. Seidella J.C. Obesity, insulin resistance and diabetes - a worldwide epidemic. Br J Nutr 83 (2000) S5-S8
7. Reddy K.S., and Yusuf S. Emerging epidemic of cardiovascular disease in developing countries. Circulation 97 (1998) 596-601
8. Melman A., and Gingell J.C. The epidemiology and pathophysiology of erectile dysfunction. J Urol 161 1 (2005) 5-11
9. Rivera J.A., Barquera S., Campiranoa F., Camposa I., Safdiea M., and Tovara V. Epidemiological and nutritional transition in Mexico: rapid increase of non-communicable chronic diseases and obesity. Public Health Nutr 5 (2002) 113-122
10. CONAPO. Proyecciones de Población 2000-2050. Mexico City: Consejo Nacional de Poblacion; 2002.
11. Barquera S., Durazo-Arvizu R.A., Luke A., Cao G., and Cooper R.S. Hypertension in Mexico and among Mexican Americans: prevalence and treatment patterns. J Hum Hypertens 22 9 (2008) 652
12. Velázquez-Monroy O., Rosas P., Lara E., and Pastelín H. Prevalencia e interrelación de enfermedades crónicas no transmisibles y factores de riesgo cardiovascular en México. Arch Cardiol Mex 73 1 (2003) 62-77
13. Rulla J.A., Aguilar-Salinasa C.A., Rojasb R., Rios-Torresa J.M., Gómez-Péreza F.J., and Olaizb G. Epidemiology of type 2 diabetes in Mexico. Arch Med Res 36 3 (2005) 188-196
14. Ugarte y Romano F., and Barroso-Aguirre J. Prevalencia de disfunción eréctil en México y factores de riesgo asociados. Rev Mex Urologia 61 (2001) 63-76
15. Hernández Moreno P.N., Mendoza Martínez R., Hernández Marín I., Tovar Rodríguez J., and Ayala A. Epidemiologic assessment of erectile function in a selected mexican population. Ginecol Obstet Mex 71 (2003) 332-342
16. Barroso-Aguirre J., and Ugarte y Romano F. Pimentel-Nieto D. Prevalencia de disfunción eréctil en hombres de 18 a 40 años en México y factores de riesgo asociados. Perinatol Reprod Hum 15 (2001) 254-261
17. Rosen R.C., Fisher W.A., Eardley I., Niederberger C., Nadel A., and Sand M. Men's attitudes to life events and sexuality (MALES) study. Curr Med Res Opin 20 5 (2004) 607-617
18. Glina S., Bertero E., Claro J., Damiao R., Faria G., Fregonesi A., et al. Efficacy and safety of flexible-dose oral sildenafil citrate (Viagra) in the treatment of erectile dysfunction in Brazilian and Mexican men. Int J Impot Res 14 Suppl 2 (2002) S27-S32
19. Fisher W.A., Rosen R.C., Eardley I., Niederberger C., Nadel A., Kaufman J., et al. The multinational men's attitudes to life events and sexuality (MALES) study. Phase II: understanding PDE5 inhibitor treatment seeking patterns, among men with erectile dysfunction. J Sex Med 1 2 (2004) 150-160